Back to today’s briefing

Story perspectives

First Patient Cured of T-Cell Leukemia with BE-CAR7 Therapy

12/9/2025

34 3 Full Breakdown

Summary

Story summary

Alyssa Tapley, from Leicester, became the first patient to receive BE-CAR7 therapy, which edits immune cells to fight T-cell leukemia.
Diagnosed in May 2021 after chemotherapy failed, she received BE-CAR7 in 2022, and her leukemia is undetectable and cancer-free.
The study published in the New England Journal of Medicine reports 64% disease-free and 82% deep remission, underscoring the need for new options for the 20% who do not respond.

1 of 1

Story summary

Alyssa Tapley, from Leicester, became the first patient to receive BE-CAR7 therapy, which edits immune cells to fight T-cell leukemia.
Diagnosed in May 2021 after chemotherapy failed, she received BE-CAR7 in 2022, and her leukemia is undetectable and cancer-free.
The study published in the New England Journal of Medicine reports 64% disease-free and 82% deep remission, underscoring the need for new options for the 20% who do not respond.